Human Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED)

Clinical trial NCT00157950 · COMPLETED

Trial details

NCT number: NCT00157950
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Papillomavirus Infections

Start date: 2005-10-01
Primary completion: 2006-06-01
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.